Directory
>
Bryan Goodwin
Bryan Goodwin
Senior Vice President, Head of Biology and Translational Sciences | Morphic Therapeutic
Boston, Massachusetts, United States
Bryan Goodwin
Summary
Bryan Goodwin is a seasoned executive in the pharmaceutical industry, currently serving as the Senior Vice President and Head of Biology and Translational Sciences at Morphic Therapeutic. With a robust background in assay development and drug discovery, he has a proven track record of leading research teams in high-stakes environments. Bryan's expertise spans across various therapeutic areas, particularly in oncology and metabolic diseases. His leadership roles at notable companies like Pfizer and Enanta Pharmaceuticals highlight his ability to drive innovation and foster collaboration. He holds a Ph.D. in Cellular and Molecular Biology from the University of Sydney, underscoring his strong scientific foundation. Bryan's career reflects a commitment to advancing therapeutic solutions, making him a key player in the industry. He is passionate about integrating emerging technologies into drug development processes, aiming to enhance patient outcomes.
Bryan Goodwin
Work Experience
Senior Vice President, Head of Biology and Translational Sciences at
Morphic Therapeutic
March 2023 - Present
Vice President, Head of Biology at
Enanta Pharmaceuticals
November 2017 - March 2023
Senior Director, Head of Gastrointestinal, Metabolic, and Endocrine Research Therapeutic Area at
SHIRE LIMITED
March 2016 - October 2017
Senior Director, Muscle Metabolism, Cardiovascular and Metabolic Disease Research Unit at
Pfizer, Inc.
April 2014 - March 2016
Director, Diabetes Prevention & Remission Group, Cardiovascular & Metabolic Disease Research Unit at
Pfizer, Inc.
October 2013 - April 2014
Lab head, Cardiovascular and Metabolic Disease Research Unit at
Pfizer, Inc.
May 2008 - September 2013
Manager at
GSK
January 1999 - January 2008
Manager at
Glaxosmithkline
January 1999 - January 2008
Bryan Goodwin
Education
The University of Sydney, Doctor Of Philosophy (Ph.D.)
January 1996 - January 1999
Frequently Asked Questions about Bryan Goodwin
What is Bryan Goodwin email address?
Bryan Goodwin's primary email address is *************@morphictx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Bryan Goodwin work for?
Bryan Goodwin is a Senior Vice President, Head of Biology and Translational Sciences at Morphic Therapeutic, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Bryan Goodwin graduated from?
Bryan Goodwin holds a degree in Cell/Cellular And Molecular Biology from The University of Sydney.
How can I directly contact Bryan Goodwin?
To contact Bryan Goodwin directly, you can use the email address *************@morphictx.com. Complete contact information is available upon registration with Muraena.
Who is Bryan Goodwin?
Bryan Goodwin is a seasoned executive in the pharmaceutical industry, currently serving as the Senior Vice President and Head of Biology and Translational Sciences at Morphic Therapeutic. With a robust background in assay development and drug discovery, he has a proven track record of leading research teams in high-stakes environments. Bryan's expertise spans across various therapeutic areas, particularly in oncology and metabolic diseases. His leadership roles at notable companies like Pfizer and Enanta Pharmaceuticals highlight his ability to drive innovation and foster collaboration. He holds a Ph.D. in Cellular and Molecular Biology from the University of Sydney, underscoring his strong scientific foundation. Bryan's career reflects a commitment to advancing therapeutic solutions, making him a key player in the industry. He is passionate about integrating emerging technologies into drug development processes, aiming to enhance patient outcomes.
Bryan`s contact details
*************@morphictx.com
*************@pfizer.com
Colleagues
Executive Director, Head of Molecular & Cellular Sciences
President
Sr. Vice President Finance & CAO
Executive Director, Head of Fibrosis
VP of DMPK & Clin Pharm
Vice President - Sr. Director, DMPK and Clinical PK at Morphic Therapeutic
VP, Head of Chemical Sciences
Vice President, Program Leadership
SVP, Technical Operations